TEMPE, Ariz., April 14, 2016 /PRNewswire-iReach/ — PROTEOR USA, a developer of next-generation prosthetic devices, announces the completion of enrollment in a definitive clinical study of the Comparative Performance of Dynamic Elastic Response Feet performed by Kenton R. Kaufman, Ph.D. of the Mayo Clinic.
The purpose of the study is to compare the functional performance of individuals with transtibial amputation using two types of prosthetic foot designs: carbon fiber vs. fiberglass composite. The study design has two outcome measures: change in gait function and change in patient satisfaction.
J. Blount Swain, President of PROTEOR USA stated, “We are pleased that Dr. Kaufman, one of the world’s leading mobility research clinicians, is conducting this study. We are optimistic that this study will begin to quantify the feedback received from amputees and certified prosthetists since the launch of the RUSH Foot® in September 2012. Amputees in the United States and 22 foreign countries have consistently reported significant improvement in their quality of life since switching to the RUSH Foot®.”
About PROTEOR USA
PROTEOR USA is a developer of next-generation prosthetic devices (https://rushfoot.com), which offers customers a range of quality products and services to suit their needs. For more information visit: https://rushfoot.com
Media Contact: Holly Sanger, PROTEOR USA, 480-361-1303, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com